Upgrade to SI Premium - Free Trial

Myriad Genetics (MYGN)

4.63 -0.06 (1.28%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (7/30/26)

Latest Headlines

Form 8-K MYRIAD GENETICS INC For: Jun 04 June 4, 2026 4:09 PM - SEC Filing Form S-8 MYRIAD GENETICS INC June 4, 2026 4:08 PM - SEC Filing Form S-8 MYRIAD GENETICS INC June 4, 2026 4:06 PM - SEC Filing Form 4 MYRIAD GENETICS INC For: Jun 01 Filed by: Jampa Raj June 2, 2026 4:21 PM - SEC Filing Form 3 MYRIAD GENETICS INC For: Jun 01 Filed by: Jampa Raj June 2, 2026 4:15 PM - SEC Filing Myriad Genetics names Raj Jampa as chief technology officer June 2, 2026 9:05 AM - StreetInsider Myriad Genetics Names Raj Jampa as New Chief Technology Officer June 2, 2026 9:05 AM - StreetInsider Myriad Genetics Highlights Data Showing Broad Clinical Utility of Precise MRD Assay at 2026 ASCO Annual Meeting May 27, 2026 9:05 AM - StreetInsider Myriad Genetics launches Prolaris + AI prostate cancer test May 26, 2026 4:06 PM - StreetInsider Myriad Genetics Launches Prolaris® + AI, the First Prostate Cancer Test to Combine Genomics and Digital Pathology Artificial Intelligence (AI) May 26, 2026 4:05 PM - StreetInsider Actress Jackie Tohn Got Results Nobody Wants But They May Have Saved Her Life May 15, 2026 11:00 AM - Globe NewsWire Form 4 MYRIAD GENETICS INC For: May 14 Filed by: Bisaro Paul May 14, 2026 5:17 PM - SEC Filing Form SCHEDULE 13G MYRIAD GENETICS INC Filed by: STATE STREET CORP May 12, 2026 11:38 AM - SEC Filing Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences May 7, 2026 4:05 PM - StreetInsider Myriad Genetics (MYGN) PT Lowered to $10 at Craig-Hallum May 6, 2026 9:35 AM - StreetInsider Myriad Genetics (MYGN) PT Lowered to $5.50 at Wells Fargo May 6, 2026 8:49 AM - StreetInsider Myriad Genetics (MYGN) PT Lowered to $6 at TD Cowen May 6, 2026 8:20 AM - StreetInsider Form 10-Q MYRIAD GENETICS INC For: Mar 31 May 6, 2026 6:08 AM - SEC Filing Myriad Genetics (MYGN) Misses Q1 EPS by 2c ; Offers Guidance May 6, 2026 2:50 AM - StreetInsider Form 8-K MYRIAD GENETICS INC For: May 05 May 5, 2026 4:09 PM - SEC Filing Myriad Genetics Reports First Quarter 2026 Financial Results; Reiterates 2026 Financial Guidance Reflecting Ongoing Progress in the Cancer Care Continuum Business May 5, 2026 4:05 PM - StreetInsider Form 4 MYRIAD GENETICS INC For: May 01 Filed by: Donnelly Brian J May 4, 2026 4:36 PM - SEC Filing Myriad Genetics National Survey: 88% of Patients with Depression and/or Anxiety Would Feel More Confident with a Personalized Mental Health Care Plan April 30, 2026 9:05 AM - Globe NewsWire Myriad Genetics to Release First Quarter 2026 Financial Results on May 5, 2026 April 28, 2026 4:05 PM - StreetInsider Myriad Genetics to Deliver Six Abstracts, Including Two Podiums, at AACR 2026 April 16, 2026 11:45 AM - Globe NewsWire Myriad Genetics to Deliver Six Abstracts, Including Two Podiums, at AACR 2026 April 16, 2026 9:15 AM - StreetInsider Form 4 MYRIAD GENETICS INC For: Apr 14 Filed by: Verratti Mark April 15, 2026 4:21 PM - SEC Filing Form 4 MYRIAD GENETICS INC For: Apr 14 Filed by: Muzzey Dale April 15, 2026 4:20 PM - SEC Filing Form ARS MYRIAD GENETICS INC For: Dec 31 April 14, 2026 5:06 PM - SEC Filing Form DEFA14A MYRIAD GENETICS INC April 14, 2026 5:03 PM - SEC Filing Form DEF 14A MYRIAD GENETICS INC For: Dec 31 April 14, 2026 5:02 PM - SEC Filing Myriad Genetics Expands Access for MyChoice Test to Prostate Cancer Patients in Japan April 14, 2026 9:15 AM - StreetInsider Myriad Genetics Underscores Commitment to Cancer Care Continuum with New Data Presentations at SGO Annual Meeting April 9, 2026 9:15 AM - StreetInsider Form SCHEDULE 13G/A MYRIAD GENETICS INC Filed by: BlackRock, Inc. April 7, 2026 1:30 PM - SEC Filing Form SCHEDULE 13G/A MYRIAD GENETICS INC Filed by: VANGUARD GROUP INC March 27, 2026 10:49 AM - SEC Filing Form 4 MYRIAD GENETICS INC For: Mar 22 Filed by: Muzzey Dale March 23, 2026 4:23 PM - SEC Filing Form 4 MYRIAD GENETICS INC For: Mar 22 Filed by: Verratti Mark March 23, 2026 4:23 PM - SEC Filing Form 4 MYRIAD GENETICS INC For: Mar 22 Filed by: Wheeler Benjamin Richard March 23, 2026 4:23 PM - SEC Filing Myriad Genetics receives FDA approval for MyChoice CDx as Zejula companion test March 17, 2026 4:05 PM - StreetInsider Myriad Genetics Receives FDA Approval of the MyChoice CDx Test as the Companion Diagnostic for Zejula (niraparib) for Patients with Ovarian Cancer  March 17, 2026 4:05 PM - StreetInsider Form 4 MYRIAD GENETICS INC For: Mar 13 Filed by: Haas Kevin Richard March 16, 2026 5:58 PM - SEC Filing Form 4 MYRIAD GENETICS INC For: Mar 12 Filed by: Muzzey Dale March 16, 2026 5:06 PM - SEC Filing Form 4 MYRIAD GENETICS INC For: Mar 12 Filed by: Donnelly Brian J March 16, 2026 5:06 PM - SEC Filing Form 4 MYRIAD GENETICS INC For: Mar 12 Filed by: Solaiman Shereen March 16, 2026 5:06 PM - SEC Filing Form 4 MYRIAD GENETICS INC For: Mar 12 Filed by: Wheeler Benjamin Richard March 16, 2026 5:06 PM - SEC Filing Form 4 MYRIAD GENETICS INC For: Mar 12 Filed by: Fox Jennifer Lynne March 16, 2026 5:06 PM - SEC Filing Form 4 MYRIAD GENETICS INC For: Mar 12 Filed by: Verratti Mark March 16, 2026 5:06 PM - SEC Filing Form 4 MYRIAD GENETICS INC For: Mar 12 Filed by: Raha Samraat S. March 16, 2026 5:06 PM - SEC Filing Form 4 MYRIAD GENETICS INC For: Mar 09 Filed by: Raha Samraat S. March 9, 2026 7:03 PM - SEC Filing Full Article List